Amryt Pharma Says European Commission Oks Filsuvez For Dystrophic And Junctional EB

Amryt Pharma To Submit Formal Dispute Resolution Request For Oleogel-S10 NDA

Biopharmaceutical company Amryt Pharma plc (AMYT) announced Friday that the company plans to submit a Formal Dispute Resolution Request (FDRR) for the company's New Drug Application (NDA) for Oleogel-S10 (Filsuvez), for the treatment of the cutaneous manifestations of Dystrophic and Junctional Epidermolysis Bullosa (EB).

RTTNews | vor 1188 Tagen

Czech Central Bank Holds Rate Steady At 3.5% On Rising Inflationary Risks

The Czech National Bank left its key interest unchanged for a third policy session in a row as policymakers assessed that inflation is set to remain elevated for the rest of the year, ruling out further easing.

RTTNews | vor 12 Minuten

U.S. Mortgage Applications Growth Slows

U.S. mortgage applications grew at a modest pace in the week ended September 19 following a surge in the previous week, survey data from the Mortgage Bankers Association showed on Wednesday.

RTTNews | vor 54 Minuten

U.S. New Home Sales Unexpectedly Skyrocket To Three-Year High In August

A report released by the Commerce Department on Wednesday showed new home sales in the U.S. unexpectedly skyrocketed to their highest level in well over three years in the month of August. The Commerce Department said new home sales soared by 20.5 percent to an annual rate of 800,000 in August after slumping by 1.8 percent to a revised rate of 664,000 in July.

RTTNews | vor 56 Minuten

Bay Street Likely To Open Slightly Higher

Modestly higher futures point to a slightly positive start for the Canadian market on Wednesday. However, uncertainty about further interest rate cuts by the Fed this year, and worries about valuations may render the mood cautious and limit market's upside.

RTTNews | vor 3Std 9 Minuten